Stockreport

Neoleukin Therapeutics Announces Scientific Advisory Board

Neoleukin Therapeutics, Inc.  (NLTX) 
PDF SEATTLE, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc. “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational me [Read more]